Please sign in to follow a disease.
Epidermolytic palmoplantar keratoderma, 1
MONDO:0007758A genetic skin disorder caused by mutations in the KRT9 gene. It is characterized by hyperkeratosis in the palms and soles resulting in abnormal thickening of the skin in these areas.
Also known as: EPPK, diffuse erythrodermic palmoplantar keratoderma, VC6rner type, diffuse erythrodermic palmoplantar keratoderma, Voerner type, epidermolytic palmoplantar keratoderma of VC6rner, epidermolytic palmoplantar keratoderma of Voerner, Ppke, diffuse erythrodermic palmoplantar keratoderma, Vörner type, epidermolytic palmoplantar keratoderma of Vörner
8 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Could a cancer pill ease rare, painful skin diseases?
Disease control Not yet recruitingThis early-phase trial tests whether low doses of erlotinib, a drug originally used for cancer, can improve symptoms of rare genetic skin conditions called keratinopathies. About 44 adults with confirmed diagnoses will take increasing doses over 24 weeks. The goal is to see if it…
Phase: PHASE1, PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Skin deep: european study probes the hidden emotional toll of skin diseases
Knowledge-focused Not yet recruitingThis study looks at how people with skin conditions (like eczema, psoriasis, or skin cancer) manage stress, feel lonely, and bounce back from challenges. Researchers will compare 375 adults with and without skin disease across 15 European countries using questionnaires. The goal …
Phase: NA • Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC